deoxyglucose has been researched along with Dyskinesia, Drug-Induced in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 4 (57.14) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bastide, MF; Bézard, E; Boraud, T; de la Crompe, B; Doudnikoff, E; Fernagut, PO; Gross, CE; Mallet, N | 1 |
| Aubert, I; Bezard, E; Bioulac, BH; Bloch, B; Crossman, AR; Dovero, S; Gross, CE; Guigoni, C; Li, Q | 1 |
| Wagner, HN | 1 |
| Andrén, PE; Gunne, LM | 1 |
| Hirato, M; Horikoshi, S; Ishihara, J; Ohye, C; Shibazaki, T | 1 |
| Gallacher, F; Gur, RC; Gur, RE; Mozley, LH; Szymanski, S | 1 |
| Andren, P; Crossman, AR; Gunne, LM; Liminga, U; Mitchell, IJ | 1 |
7 other study(ies) available for deoxyglucose and Dyskinesia, Drug-Induced
| Article | Year |
|---|---|
Inhibiting Lateral Habenula Improves L-DOPA-Induced Dyskinesia.
Topics: Animals; Corpus Striatum; Daunorubicin; Deoxyglucose; Disease Models, Animal; Dyskinesia, Drug-Induced; Electrophysiology; Female; Genes, Immediate-Early; Habenula; Levodopa; Macaca fascicularis; Male; Oxidopamine; Parkinson Disease; Rats; Rats, Sprague-Dawley | 2016 |
Involvement of sensorimotor, limbic, and associative basal ganglia domains in L-3,4-dihydroxyphenylalanine-induced dyskinesia.
Topics: Animals; Basal Ganglia; Deoxyglucose; Dyskinesia, Drug-Induced; Female; Globus Pallidus; Levodopa; Limbic System; Macaca fascicularis; Motor Cortex; Parkinsonian Disorders; Septal Nuclei; Somatosensory Cortex; Substantia Nigra; Subthalamic Nucleus | 2005 |
Imaging CNS receptors: the dopaminergic system.
Topics: Animals; Antipsychotic Agents; Apomorphine; Binding Sites; Brain; Carbon Radioisotopes; Deoxyglucose; Dyskinesia, Drug-Induced; Fluorine; Haloperidol; Humans; Parkinson Disease; Radioisotopes; Receptors, Dopamine; Schizophrenia; Spiperone; Tomography, Emission-Computed; Tritium | 1984 |
[What is the connection between Parkinson disease and tardive dyskinesia?].
Topics: Animals; Antipsychotic Agents; Deoxyglucose; Dyskinesia, Drug-Induced; gamma-Aminobutyric Acid; Haplorhini; Humans; Models, Biological; Parkinson Disease; Receptors, Dopamine | 1994 |
Parkinsonian rigidity, dopa-induced dyskinesia and chorea--dynamic studies on the basal ganglia-thalamocortical motor circuit using PET scan and depth microrecording.
Topics: Antiparkinson Agents; Basal Ganglia; Blood Glucose; Brain; Brain Mapping; Cerebral Cortex; Chorea; Deoxyglucose; Dyskinesia, Drug-Induced; Electrodes, Implanted; Energy Metabolism; Fluorodeoxyglucose F18; Globus Pallidus; Humans; Levodopa; Motor Neurons; Neural Pathways; Neurologic Examination; Parkinson Disease; Stereotaxic Techniques; Thalamic Nuclei; Tomography, Emission-Computed; Tremor | 1995 |
Vulnerability to tardive dyskinesia development in schizophrenia: an FDG-PET study of cerebral metabolism.
Topics: Adult; Brain; Deoxyglucose; Disease Susceptibility; Dyskinesia, Drug-Induced; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Schizophrenia; Tomography, Emission-Computed | 1996 |
Regional changes in 2-deoxyglucose uptake associated with neuroleptic-induced tardive dyskinesia in the Cebus monkey.
Topics: Animals; Autoradiography; Blood Glucose; Brain; Brain Mapping; Cebus; Densitometry; Deoxyglucose; Dyskinesia, Drug-Induced; Fluphenazine; Globus Pallidus; Thalamic Nuclei | 1992 |